Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00923312 · COMPLETED
Trial details
- NCT number
- NCT00923312
- Sponsor
- CureVac
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2012-02-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.